Published April 2021 | Version v1
Journal article

Exploitation of Aspergillus flavus synthesized copper oxide nanoparticles as a novel medical agent

  • 1. Egyptian Atomic Energy Authority, Cairo (Egypt). Labeled Compounds Department, Hot Labs Center
  • 2. AL-Azhar University, Nasr City, Cairo (Egypt). Regional Center for Mycology and Biotechnology
  • 3. AL-Azhar University, Nasr City, Cairo (Egypt). Botany and Microbiology Department, Faculty of Science
  • 4. Egyptian Atomic Energy Authority, Cairo (Egypt). Radioisotopes Production Facility, Second Egyptian Research Reactor Complex
  • 5. Egyptian Atomic Energy Authority, Cairo (Egypt). Radioactive Isotopes and Generator Department, Hot Labs Center

Description

This study was designed to biosynthesize Aspergillus flavus copper oxide NPs (AFCuONPs) using extracellular fungous filtrate technique and evaluating its medical importance. AFCuONPs were successfully biosynthesized with average size of 32.4 nm and zeta potential of - 36 mV. They were fully characterized using FT-IR, UV-Vis spectrophotometry, and TEM. AFCuONPs cytotoxicity and bactericidal activity were evaluated against different cell lines and pathogenic bacteria, respectively. [99mTc]Tc-AFCuONPs were radiosynthesized with high radiolabeling yield (93 ± 0.85%). In vivo biodistribution of [99mTc]Tc-AFCuONPs in tumor-bearing mice model showed high tumor uptake. These results introduce AFCuONPs as a promising medical agent. (author)

Additional details

Publishing Information

Journal Title
Journal of Radioanalytical and Nuclear Chemistry
Journal Volume
328
Journal Issue
1
Journal Page Range
p. 299-313
ISSN
0236-5731
CODEN
JRNCDM

Optional Information

Notes
80 refs.